Knowra Indometacin Indometacin Indometacin is a nonsteroidal anti-inflammatory drug that reduces pain, fever, and inflammation by inhibiting cyclooxygenase enzymes and prostaglandin production.
Cyclooxygenase : Cyclooxygenase enzymes convert arachidonic acid into prostaglandin precursors. Indometacin inhibits these enzymes, reducing the production of inflammatory prostaglandins.
Gout : Gout is an inflammatory arthritis caused by urate crystals accumulating in joints. Indometacin can relieve pain and inflammation during acute gout attacks.
Ibuprofen : Ibuprofen is a widely used nonsteroidal anti-inflammatory drug for pain, fever, and inflammation. It offers similar broad symptom relief and is often chosen for its more favorable tolerability.
Pharmacokinetics : Pharmacokinetics describes how a body absorbs, distributes, metabolizes, and eliminates a drug. These processes determine indometacin’s dosing intervals and how long its effects persist.
Nonsteroidal anti-inflammatory drug development : Nonsteroidal anti-inflammatory drug development is the history and science of creating medicines that reduce pain and inflammation without steroids. Indometacin emerged during efforts to develop potent alternatives to corticosteroid therapy.
Prostaglandin : Prostaglandins are lipid signaling molecules involved in inflammation, pain, fever, and many normal body functions. Their reduced synthesis mediates indometacin’s therapeutic effects and several adverse effects.
Rheumatoid arthritis : Rheumatoid arthritis is a chronic autoimmune disease that inflames joints and can damage them over time. Indometacin can ease its symptoms but does not stop the underlying immune damage.
Celecoxib : Celecoxib is a selective cyclooxygenase-2 inhibitor used to treat pain and inflammation. Its greater COX-2 selectivity distinguishes its gastrointestinal and cardiovascular risk profile from indometacin’s.
Oral administration : Oral administration delivers a drug through the mouth for absorption in the digestive tract. Indometacin is commonly taken orally, a route that can contribute to gastrointestinal irritation.
Merck & Co. : Merck & Co. is an American pharmaceutical company founded in 1891. The company developed indometacin, which entered clinical use in the 1960s.
Show all 27